Glutathione injectable recalled over sterility concerns
- Recall date
- August 21, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Auro Pharmacies, Inc. recalls Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Hab…
- Recall number
- D-1159-2018
- FDA classification
- Class II
- Brand / firm
- Auro Pharmacies, Inc.
- Sold / distributed
- Nationwide in USA
Why it was recalled
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Get recall alerts
Free email alert whenever Auro Pharmacies, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Auro Pharmacies, Inc.